EA201071001A1 - Способ получения комбретастатина - Google Patents

Способ получения комбретастатина

Info

Publication number
EA201071001A1
EA201071001A1 EA201071001A EA201071001A EA201071001A1 EA 201071001 A1 EA201071001 A1 EA 201071001A1 EA 201071001 A EA201071001 A EA 201071001A EA 201071001 A EA201071001 A EA 201071001A EA 201071001 A1 EA201071001 A1 EA 201071001A1
Authority
EA
Eurasian Patent Office
Prior art keywords
formula
salt
base
combretastatin
compound
Prior art date
Application number
EA201071001A
Other languages
English (en)
Inventor
Марк Фредерик
Сильвиан Лютц
Жоэль Мальпар
Филипп Массон
Стефан Мютти
Original Assignee
Санофи-Авентис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39816950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201071001(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Санофи-Авентис filed Critical Санофи-Авентис
Publication of EA201071001A1 publication Critical patent/EA201071001A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/18Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Изобретение относится к способу получения комбретастатина (А) формулы (I) в форме основания или кислотно-аддитивной соли, который включает в себя реакцию сочетания, в присутствии основания и соединения Т3Р, соли (Z)-аминосоединения формулы (II) с дважды защищенным производным L-серина формулы (III), в которой PG означает защитную группу для аминогруппы, с получением соединения (Z)-(Ib) формулы (IV), затем удаление защиты и раскрытие цикла (Z)-(Ib) в присутствии кислоты, чтобы получить комбретастатин (А) в форме соли и, необязательно, добавление основания, чтобы получить комбретастатин (А) в форме основания, причем соль (Z)-аминосоединения была получена обогащением соли аминосоединения формулы (V) (Z)-изомером.
EA201071001A 2008-02-28 2009-02-27 Способ получения комбретастатина EA201071001A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0801092A FR2928148B1 (fr) 2008-02-28 2008-02-28 Procede de preparation de combretastatine
PCT/FR2009/000215 WO2009118474A1 (fr) 2008-02-28 2009-02-27 Procede de preparation de combretastatine

Publications (1)

Publication Number Publication Date
EA201071001A1 true EA201071001A1 (ru) 2011-02-28

Family

ID=39816950

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201300249A EA201300249A1 (ru) 2008-02-28 2009-02-27 Способ обогащения соли аминосоединения
EA201071001A EA201071001A1 (ru) 2008-02-28 2009-02-27 Способ получения комбретастатина

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA201300249A EA201300249A1 (ru) 2008-02-28 2009-02-27 Способ обогащения соли аминосоединения

Country Status (28)

Country Link
US (1) US20110124899A1 (ru)
EP (2) EP2562154A1 (ru)
JP (1) JP2011513286A (ru)
KR (1) KR20100116644A (ru)
CN (1) CN102015620A (ru)
AR (1) AR072772A1 (ru)
AU (1) AU2009229027A1 (ru)
BR (1) BRPI0907999A2 (ru)
CA (1) CA2716541A1 (ru)
CL (3) CL2009000463A1 (ru)
CO (1) CO6241150A2 (ru)
CR (1) CR11635A (ru)
DO (1) DOP2010000250A (ru)
EA (2) EA201300249A1 (ru)
EC (1) ECSP10010421A (ru)
FR (1) FR2928148B1 (ru)
HN (1) HN2010001700A (ru)
IL (2) IL207754A0 (ru)
MA (1) MA32193B1 (ru)
MX (1) MX2010009514A (ru)
NI (1) NI201000144A (ru)
NZ (1) NZ587505A (ru)
PE (1) PE20091559A1 (ru)
SG (1) SG183658A1 (ru)
TW (1) TW200948753A (ru)
UY (1) UY31681A1 (ru)
WO (1) WO2009118474A1 (ru)
ZA (1) ZA201006137B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
WO2013084150A1 (en) * 2011-12-06 2013-06-13 Sanofi Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof
EP2805705B1 (en) 2013-05-23 2016-11-09 IP Gesellschaft für Management mbH Packaging with one or more administration units comprising a sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1 H-imidazol-4-yl)-propionic acid
CN104447598B (zh) * 2013-09-18 2017-09-22 浙江大德药业集团有限公司 Ca‑4的大环多胺衍生物及其抗肿瘤特性
CN104817519B (zh) * 2015-05-11 2016-11-16 中国药科大学 一类ca-4的衍生物、其制法及其医药用途
CN104892668B (zh) * 2015-05-12 2017-03-29 上海大学 考布他汀类似物水溶性前‑前药及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1217500A (en) * 1967-05-24 1970-12-31 Ici Ltd Separation of trans-trans enriched salts of 4,4'-diaminodicyclohexylmethane
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
US5731353A (en) 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
US5561122A (en) 1994-12-22 1996-10-01 Arizona Board Of Regents Acting On Behalf Of Arizona State University Combretastatin A-4 prodrug
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JPH08272028A (ja) * 1995-03-30 1996-10-18 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料およびその製造方法
JP2000239274A (ja) * 1998-12-16 2000-09-05 Nippon Kayaku Co Ltd 新規ナフチリジン誘導体の製造法
ES2281374T3 (es) * 1999-12-21 2007-10-01 Teva Pharmaceutical Industries Ltd. Nuevos polimorfos de hidrocloruro de sertralina, procedimientos para su preparacion, composiciones que los contienen y metodos para su utilizacion.
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US6759555B2 (en) * 2002-04-11 2004-07-06 Aventis Pharma S.A. Process for the preparation of combretastatins
DE10333042B4 (de) * 2003-07-21 2005-09-29 Clariant Gmbh Verfahren zur Herstellung von cyclischen Phosphonsäureanhydriden und deren Verwendung

Also Published As

Publication number Publication date
TW200948753A (en) 2009-12-01
AU2009229027A1 (en) 2009-10-01
AR072772A1 (es) 2010-09-22
ECSP10010421A (es) 2010-09-30
NZ587505A (en) 2012-06-29
CA2716541A1 (fr) 2009-10-01
CN102015620A (zh) 2011-04-13
MX2010009514A (es) 2010-12-15
ZA201006137B (en) 2011-11-30
CR11635A (es) 2011-02-04
CO6241150A2 (es) 2011-01-20
KR20100116644A (ko) 2010-11-01
BRPI0907999A2 (pt) 2019-01-15
FR2928148B1 (fr) 2013-01-18
UY31681A1 (es) 2009-09-30
JP2011513286A (ja) 2011-04-28
DOP2010000250A (es) 2010-09-30
WO2009118474A1 (fr) 2009-10-01
PE20091559A1 (es) 2009-10-30
EP2252572A1 (fr) 2010-11-24
WO2009118474A8 (fr) 2010-09-10
FR2928148A1 (fr) 2009-09-04
CL2012001744A1 (es) 2012-10-12
NI201000144A (es) 2011-03-09
EP2562154A1 (fr) 2013-02-27
IL225776A0 (en) 2013-06-27
CL2012001742A1 (es) 2012-11-16
EA201300249A1 (ru) 2013-08-30
SG183658A1 (en) 2012-09-27
CL2009000463A1 (es) 2010-12-03
IL207754A0 (en) 2010-12-30
HN2010001700A (es) 2013-06-17
US20110124899A1 (en) 2011-05-26
MA32193B1 (fr) 2011-04-01

Similar Documents

Publication Publication Date Title
EA201071001A1 (ru) Способ получения комбретастатина
BRPI0905147A8 (pt) processo para síntese de ivabradina e seus sais de adição com um ácido farmaceuticamente aceitável
EA200970149A1 (ru) Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии
PE20091440A1 (es) Profarmacos de peptidos basados en esteres
CY1116498T1 (el) Διεργασια για την παρασκευη (r)-(-)-3-(καρβαμοϋλομεθυλ)-5-μεθυλεξανοϊκου οξεος και πρεγκαμπαλινης και συνθεση ενδιαμεσων
EA201291436A1 (ru) Производные гексафторизопропил карбамата, их получение и их терапевтическое применение
CO6531500A2 (es) Composiciones y metodos para el tratamiento de la xerostomia
EA201200031A1 (ru) Инсектицидные соединения
MY151993A (en) Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
DE602006008962D1 (de) Verfahren zur herstellung von valsartan
EA201290872A1 (ru) Способ получения бензоксаборолов
EA201190293A1 (ru) Пролекарства триптолида
ATE477234T1 (de) Synthese von phenolischen estern von hydroxymethylphenolen
EA201170983A1 (ru) Производные тиадиазолов и оксадиазолов, их получение и их применение в терапии
WO2010128516A3 (en) Process for the preparation of flibanserin involving novel intermediates
EA201101147A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
BR122018074319B8 (pt) Método para preparar um composto de fórmula 14
EA201000398A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
DOP2006000095A (es) Derivados de aminoacidos
EA201200498A1 (ru) Новый способ синтеза ивабрадина и его фармацевтически приемлемых кислотно-аддитивных солей
AP2007004270A0 (en) Process for preparing salts of hydrocyanic acid
EA201000397A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
EA201170526A1 (ru) Тиазолилпиразолопиримидины в качестве синтетических промежуточных соединений и связанные с ними способы синтеза
EA201001270A1 (ru) Новый способ получения сульфонилпирролов в качестве ингибиторов гистондезацетилаз (hdac)
TN2010000384A1 (en) Method for preparing combretastatin